Sign Out
The vaccine is indicated for using in individuals aged ≥2 years who are at increased risk of pneumococcal disease.
The vaccine elicits immune response in recipients following immunization and is indicated for the prevention of pneumococcal diseases caused by the 23 serotypes contained in the vaccine (1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F, and 33F). The vaccine will not prevent diseases caused by capsular types of Streptococcus pneumoniae other than those contained in the vaccine.
Continue with Google